Skip to main content
All lobbying filings

HORIZONS GLOBAL SOLUTIONS LLC

HORIZONS GLOBAL SOLUTIONS LLC filed a Q3 report for CAPTURA BIOPHARMA on October 13, 2026, reporting no lobbying activity.

Lobbying for CAPTURA BIOPHARMA · Captura is developing an orally administered MCM for radionuclide contamination.

All filings by HORIZONS GLOBAL SOLUTIONS LLC · Everything CAPTURA BIOPHARMA has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 19, 2026.
 Filing · LD-2 quarterly report Q3 reportNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 13, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Arkansas

Official filing document

 Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem